Omega-3 Fatty Acids in Modern Parenteral Nutrition: A Review of the Current Evidence
AbstractIntravenous lipid emulsions are an essential component of parenteral nutrition regimens. Originally employed as an efficient non-glucose energy source to reduce the adverse effects of high glucose intake and provide essential fatty acids, lipid emulsions have assumed a larger therapeutic role due to research demonstrating the effects of omega-3 and omega-6 polyunsaturated fatty acids (PUFA) on key metabolic functions, including inflammatory and immune response, coagulation, and cell signaling. Indeed, emerging evidence suggests that the effects of omega-3 PUFA on inflammation and immune response result in meaningful therapeutic benefits in surgical, cancer, and critically ill patients as well as patients requiring long-term parenteral nutrition. The present review provides an overview of the mechanisms of action through which omega-3 and omega-6 PUFA modulate the immune-inflammatory response and summarizes the current body of evidence regarding the clinical and pharmacoeconomic benefits of intravenous n-3 fatty acid-containing lipid emulsions in patients requiring parenteral nutrition. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Klek, S. Omega-3 Fatty Acids in Modern Parenteral Nutrition: A Review of the Current Evidence. J. Clin. Med. 2016, 5, 34.
Klek S. Omega-3 Fatty Acids in Modern Parenteral Nutrition: A Review of the Current Evidence. Journal of Clinical Medicine. 2016; 5(3):34.Chicago/Turabian Style
Klek, Stanislaw. 2016. "Omega-3 Fatty Acids in Modern Parenteral Nutrition: A Review of the Current Evidence." J. Clin. Med. 5, no. 3: 34.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.